Cohlhepp Ryan 4
4 · Bicara Therapeutics Inc. · Filed Jan 20, 2026
Insider Transaction Report
Form 4
Cohlhepp Ryan
DirectorPresident and COO
Transactions
- Sale
Common Stock
[F1]2026-01-15$18.02/sh−149$2,685→ 213,992 total
Footnotes (1)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.
Signature
/s/ Lara Meisner, Attorney-in-Fact|2026-01-20